logo
Plus   Neg
Share
Email

Alexion Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates

Alexion Pharmaceuticals Inc. (ALXN) announced earnings for its first quarter that climbed from last year.

The company's bottom line totaled $587.9 million, or $2.61 per share. This compares with $249.1 million, or $1.11 per share, in last year's first quarter.

Excluding items, Alexion Pharmaceuticals Inc. reported adjusted earnings of $545.5 million or $2.39 per share for the period.

Analysts had expected the company to earn $2.19 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 22.6% to $1.14 billion from $0.93 billion last year.

Alexion Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q1): $545.5 Mln. vs. $380.6 Mln. last year.
-EPS (Q1): $2.39 vs. $1.68 last year.
-Analysts Estimate: $2.19
-Revenue (Q1): $1.14 Bln vs. $0.93 Bln last year.

-Guidance:
Full year EPS guidance: $9.25 to $9.45
Full year revenue guidance: $4,675 to $4,750 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT
>